Shots:
Nanexa has entered into a global exclusive license & collaboration agreement with Novo for the use of its PharmaShell ALD drug delivery technology platform, for certain peptide-based drugs targeting obesity, T2D & other cardiometabolic indications
As per the deal, Novo will receive a global license to Nanexa’s PharmaShell platform for use in ~5 development programs,…
